Investors have “overly punished” Iren, says JPMorgan.
Related Posts
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea, expanding use in U.S.
The agency’s decision expands the use of Zepbound and could potentially pave the way for Eli Lilly to gain broader insurance coverage for the treatment.
The Federal Reserve cuts interest rates by a quarter point after election. Here’s what that means for you
The second interest rate cut in a row will affect consumer borrowing costs. Here’s what it means for your credit card, mortgage rate, car loan […]
Amazon’s Zoox robotaxi unit issues second software recall in a month after San Francisco crash
Zoox’s recall comes after an unoccupied robotaxi was struck by an e-scooter rider at an intersection earlier this month.